MERIDIAN BIOSCIENCE, INC. FDA Inspection Record

FEI 1524213 · Inspections, Form 483s, warning letters and import refusals

MERIDIAN BIOSCIENCE, INC. is an FDA-registered facility (FEI 1524213) located in Cincinnati, OH, US. RegDataLab tracks 3 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Nov 17, 2017: No Action Indicated (NAI)
Inspections on record
3 (3 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
11, latest Dec 5, 2025

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Nov 17, 2017No Action Indicated (NAI)Lack of or inadequate procedures (21 CFR 820.100(a))
Jun 12, 2014No Action Indicated (NAI)No citations listed
Mar 21, 2013No Action Indicated (NAI)No citations listed

Recalls

Showing the 10 most recent of 11 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Dec 5, 2025Class IIZ-1019-2026Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene…
The affected lots show a decline in performance over time, which may lead to false-negative results.
Oct 7, 2025Class IIZ-0568-2026Meridian Bioscience, alethia c. Difficile, Catalog Number 480050, Nucleic Acid… and 1 more product
The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.
Oct 19, 2023Class IIZ-0519-2024Para-Pak Clean Vial-For the collection, transportation, preservation, and examination of… and 2 more products
Plastic vials contain a manufacturing defect may cause an increased risk of leakage and presents a risk of incidental exposure to…
Dec 15, 2022Class IIZ-1008-2023Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of…
Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to…
Jun 22, 2022Class IIZ-1479-2022Revogene, Catalog no. 610210. IVD test instrument
When a run is aborted, the cooling period protection does not occur and the user is able to open the lid prior to the completion of the…
Feb 15, 2022Class IIZ-0836-2022Revogene, For In Vitro Diagnostic use in performing nucleic acid testing in clinical…
The photomultiplier tube, may have compromised functionality in some instruments. As a result, the user is likely to observe an increase in…
Apr 8, 2021Class IIZ-1540-2021Revogene SARS-CoV-2 Catalog Number: 410700 IVD for real-time Reverse Transcription… and 1 more product
Emergency Use Application (EUA) application withdrawn as false negative results reported
Feb 8, 2021Class IIZ-1299-2021The ImmunoCard Mycoplasma EIA detects the presence of IgM to M. pneumoniae in serum…
Use of the kits after incorrect storage could lead to a potential false-negative or invalid result. In the event of a false-negative, the…
Dec 17, 2018Class IIZ-0732-2019PREMIER Cryptococcal Antigen, Catalog Number 602096 Product Usage: The PREMIER…
An enzyme reagent included in the kit is not maintaining stability through claimed product expiration, resulting in the potential for false…
Nov 8, 2016Class IIZ-1033-2017PREMIER EHEC and PREMIER EHEC Bulk.
Internal testing has demonstrated that the indicated kit lots produce false positive results when tested with some broth specimens.

FDA record score

21 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 22, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

11 records behind this number
RecordDatePoints x age weightAdds
Class II recall Z-1019-2026, this FEI as the recalling firmDec 5, 20254 x 14
Class II recall Z-0568-2026, this FEI as the recalling firmOct 7, 20254 x 14
Class II recall Z-0519-2024, this FEI as the recalling firmOct 19, 20234 x 0.62.4
Class II recall Z-1008-2023, this FEI as the recalling firmDec 15, 20224 x 0.62.4
Class II recall Z-1479-2022, this FEI as the recalling firmJun 22, 20224 x 0.62.4
Class II recall Z-0836-2022, this FEI as the recalling firmFeb 15, 20224 x 0.62.4
Class II recall Z-1540-2021, this FEI as the recalling firmApr 8, 20214 x 0.251
Class II recall Z-1299-2021, this FEI as the recalling firmFeb 8, 20214 x 0.251
Class II recall Z-0732-2019, this FEI as the recalling firmDec 17, 20184 x 0.251
Class II recall Z-1033-2017, this FEI as the recalling firmNov 8, 201610 years or older, so it adds no points0
Class II recall Z-1941-2014, this FEI as the recalling firmApr 22, 201410 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 22, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 22, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 22, 2026Newest record Nov 13, 2026Current
Warning letter textNov 22, 2026Newest record Nov 17, 2026Current
Recalls (Enforcement Report)Nov 22, 2026Newest record Nov 18, 2026Current
Form 483s and inspection documentsNov 18, 2026Newest record Nov 17, 2026Current
Import refusalsNov 22, 2026Newest record Nov 12, 2026Current

Reviewing MERIDIAN BIOSCIENCE, INC. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check MERIDIAN BIOSCIENCE, INC. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Meridian Bioscience Inc
Location
Cincinnati, OH (US)
Source
device

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.